CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells
CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells
复制标题
CD19( )IL-10( ) 调节性 B 细胞影响舌鳞状细胞癌患者的生存并诱导静息 CD4( ) T 细胞转变为 CD4( )Foxp3( ) 调节性 T 细胞
DOI:
10.1016/j.oraloncology.2015.11.003
复制
发表时间:
2016
期刊:
影响因子:
4.8
通讯作者:
Liao Gui-Qing
中科院分区:
文献类型:
--
作者:
Zhou Xi;Su Yu-Xiong;Lao Xiao-Mei;Liang Yu-Jie;Liao Gui-Qing
ObjectivesIncrease of regulatory T cells (Tregs) in the tumor microenvironment predicts worse survival of patients with various types of cancer including tongue squamous cell carcinoma (TSCC). Recently, the cross-talk between Tregs and regulatory B cells (Bregs) has been shown in several tumor models. However the relevance of Bregs to tumor immunity in humans remains elusive. Our objective was to investigate the distribution and function of Bregs in TSCC microenvironment.Materials and MethodsDouble staining (Bregs: IL10/CD19 and Tregs: Foxp3/CD4) was performed on tissue sections of 46 TSCC, 20 metastasis lymph nodes, and tumor adjacent normal tissue. Flow cytometry analysis was used to detect the Bregs from magnetic bead-sorted B cells after co-culture with TSCC cell lines, and Tregs from sorted CD4+CD25−T cells after co-culture with stimulated B cells.ResultsThe immunohistochemical (IHC) results showed that the frequency of Bregs/CD19+B in TSCC (0.80 ± 0.08%) was significantly higher than adjacent normal tissue (0.52 ± 0.04%p< 0.01). And the increase of Bregs in TSCC microenvironment was related to Tregs and predicts worse survival in patients. Cytological experiments indicated that frequency of Bregs increased after co-culture with TSCC cell line and that the induced B cells converted CD4+CD25−T cells into Tregs.ConclusionThe increased expression of Bregs in the TSCC microenvironment plays a significant role in the differentiation of resting CD4+T cells and influenced the prognosis of TSCC patients.